What are the best returns in our portfolio?
Published 12-FEB-2021 13:40 P.M.
3 minute read
We have no new investment to announce today.
Our model is to write about the companies we have invested in, and we do a lot of research before we make a new investment - which takes time to do properly.
If we haven't invested in a company for the long term, we won’t write about it.
Carefully choosing our investments and long-term holding has been a successful strategy for us.
Some of the earliest investments in our portfolio that have provided the best returns (we did months of research before we invested) include VUL (4,928%), WHK (525%), EXR (323%), MYQ (1426%).
We believe in holding a position for long enough to see the company deliver its business plan - this is where the biggest gains are made if the company is successful.
So while there is no new investment to announce today, here are three movers and shakers from our portfolio this week:
Invictus Energy (ASX: IVZ) is one of the quieter achievers in our portfolio. This week it popped on no news, hitting a high of 8.7c and settling in a new average range of around 7.8c - continuing a nice upward trend over the last four weeks.
IVZ was our top energy pick for 2020, after we first took a position in September last year when it was trading at $0.049.
Currently capped at $36.5M, IVZ has a massive gas project in northern Zimbabwe comprising 9.25 trillion cubic feet (Tcf) of gas plus 294 million barrels of conventional gas/condensate (gross mean unrisked).
After years of work, the company is edging closer to a farm out to drill test the project.
- A non-binding MoU has been signed for a farm out. ✅
- Its PEDPA has been reviewing and IVZ is awaiting sign off ✅
- Significant progress has been made on executing a seismic acquisition program. ✅
All of this leads into the event we have all been waiting for - a high impact, basin opening drilling campaign to test the hydrocarbon potential of IVZ’s project.
Success on drilling this giant energy project would be truly transformational for IVZ, and with few shares on issue, we are expecting its valuation to increase as key milestones are ticked off.
In our note a few days ago we highlighted how MyFiziq (ASX: MYQ)’s share price had started running from $1 to $1.34...
Today it hit $1.86 - a pretty epic run.
MYQ has developed patented health tech that allows an individual to accurately track the dimensions of their body directly from a smartphone.
We are long term holders in MYQ and have invested multiple times over the last 12 months with the most recent investment being made at the 86c mark.
Three things we like about MYQ:
- Health Tech is hot global thematic ✅
- ESG credentials ✅
- NASDAQ listing coming. ✅
MYQ is an ESG company in the hot health tech sector, with a timeline to list on the US NASDAQ - three factors that set them up for future success.
This week, Vulcan Energy (ASX: VUL) revealed mining magnate Gina Rinehart bought 7,241,200 shares - $47,067,800. It’s a large, but strange number... it looks to us like they were scaled back with the rest of us.
Also, VUL has once again caught the attention of our favourite German resource house, Alster.
Alster continues to place share price targets for VUL to destroy (remember $2.43... $9.50...). Alster has just just come out with a brand new target of AU$13.30.
VUL has a rich and long history of beating up Alster's price targets.
Also now with $120M in the bank, VUL is ready to start accelerating its project. The first step was to buy 100% of geothermal sub-surface consultancy company GeoThermal Engineering GmbH (GeoT).
The GeoT acquisition is but one of a sizable list of Vulcan’s promising developments announced in recent months, with more to come shortly.
We will bring you a new investment soon, in the meantime check out our portfolio of current holdings ...
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.